%0 Journal Article
%A 
%T Cost-Effectiveness of Pembrolizumab in Combination with Platinum-Based Chemotherapy in First-Line for Squamous and Nonsquamous Non Small-Cell Lung Cancer. Far from Economic Sustainability
%D 2021
%F 
%P 59-62
%V 5
%N 1
%R doi:10.14744/ejmo.2021.96518
%U https://dx.doi.org/10.14744/ejmo.2021.96518